Filing Details

Accession Number:
0001225208-14-007301
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-03-04 16:44:57
Reporting Period:
2014-02-28
Filing Date:
2014-03-04
Accepted Time:
2014-03-04 16:44:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
885725 Boston Scientific Corp BSX Surgical & Medical Instruments & Apparatus (3841) 042695240
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1483825 Fitterer Jean Lance One Boston Scientific Place
Natick MA 01760-1537
Svp & Chief Compliance Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-02-28 4,190 $0.00 121,667 No 4 M Direct
Common Stock Acquisiton 2014-02-28 3,382 $0.00 125,049 No 4 M Direct
Common Stock Disposition 2014-02-28 2,545 $13.10 122,504 No 4 F Direct
Common Stock Disposition 2014-02-28 10,000 $13.20 112,504 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 F Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Deferred Stock Units Disposition 2014-02-28 3,382 $0.00 3,382 $0.00
Common Stock Deferred Stock Units Disposition 2014-02-28 4,190 $0.00 4,190 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
46,614 No 4 M Direct
42,424 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 7,661 Indirect By 401(k)
Footnotes
  1. Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
  2. Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.
  3. Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $13.190 to $13.201, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  4. Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan.
  5. Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 28, 2014, the first anniversary of the date of grant.
  6. Reflects multiple DSU awards with independent vesting schedules.
  7. Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 28, 2012, the first anniversary of the date of grant.